| # | Drug | Count |
|---|---|---|
| 0 | IRBESARTAN | 3 |
| 1 | LAMOTRIGINE | 3 |
| 2 | PREDNISOLONE | 3 |
| 3 | PREDNISOLONE ORAL | 3 |
| 4 | PREDNISOLONE ORAL SOLUTION | 3 |
| 5 | PREDNISONE | 3 |
| 6 | ATEZOLIZUMAB | 2 |
| 7 | BEVACIZUMAB | 2 |
| 8 | CARBOPLATIN | 2 |
| 9 | LAMOTIRIGINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 1 | LEMBOREXANT | 1 | 0.0003 |
| 2 | LETERMOVIR | 1 | 0.0003 |
| 3 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 4 | ATOVAQUONE | 1 | 0.0001 |
| 5 | DRONEDARONE | 1 | 0.0001 |
| 6 | CEFUROXIME | 1 | 0.0001 |
| 7 | APALUTAMIDE | 1 | 0.0001 |
| 8 | AMPHOTERICIN B | 1 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Antimalarial [EPC] | 1 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 5 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |